MENU
ENZB
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Enzo Biochem (ENZB) Ownership - Who owns Enzo Biochem?
Enzo Biochem Inc is a bioscience company... Show more
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
36.2M
P/E Ratio
N/A
Total Cash
36.69M
Projected Growth
N/A
Total Debt
3M
Revenue
27.47M
Risk (Beta)
1.53
Dividend Yield
0.14
Total Cash/Share
0.70
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price
Fundamentals
ENZB
Capitalization
36.2M
P/E Ratio
N/A
Risk (Beta)
1.53
Dividend Yield
0.14
Total Cash
36.7M
Total Cash/Share
0.70
Total Debt
3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
27.5M
ROE
N/A
Book Value
43.4M
P/B Ratio
0.83
Cash Flow
N/A
Earnings
-0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
523K
Current Ratio
2.84
Current Revenue Per Employee
47073.53
Dividends Per Share - Security
0.00
EBITDA
-7.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
38.80
Revenue To Assets
-26.86
Shares Held By Institutions
6.29M
Shares Outstanding - Current
52.4M
Total Liabilities
20.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-3.203
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information